14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $5.34 $19.02 Tuesday, 7th May 2024 CNTA stock ended at $9.67. This is 4.54% more than the trading day before Monday, 6th May 2024. During the day the stock fluctuated 8.73% from a day low at $8.93 to a day high of $9.71.
90 days $17.30 $19.02
52 weeks $16.32 $20.85

Historical Centessa Pharmaceuticals Limited prices

Date Open High Low Close Volume
Jul 26, 2021 $21.40 $21.92 $20.87 $21.04 391 033
Jul 23, 2021 $21.28 $21.89 $20.55 $21.49 48 801
Jul 22, 2021 $20.97 $21.50 $20.51 $21.14 56 682
Jul 21, 2021 $21.11 $21.44 $20.79 $20.99 239 584
Jul 20, 2021 $21.13 $22.77 $20.71 $21.32 400 971
Jul 19, 2021 $19.61 $21.81 $19.61 $21.32 441 147
Jul 16, 2021 $21.32 $21.84 $20.50 $21.08 194 423
Jul 15, 2021 $21.98 $22.86 $20.33 $20.87 181 840
Jul 14, 2021 $22.83 $23.25 $21.36 $21.54 101 492
Jul 13, 2021 $21.65 $22.94 $21.11 $22.26 237 577
Jul 12, 2021 $21.92 $22.49 $21.21 $21.86 132 931
Jul 09, 2021 $21.20 $22.31 $20.85 $21.93 66 088
Jul 08, 2021 $20.51 $21.36 $20.40 $21.19 108 014
Jul 07, 2021 $22.01 $22.52 $20.45 $21.01 546 063
Jul 06, 2021 $22.31 $22.83 $21.68 $21.81 106 545
Jul 02, 2021 $22.55 $22.87 $21.48 $22.12 104 646
Jul 01, 2021 $22.33 $23.14 $21.37 $22.55 273 784
Jun 30, 2021 $22.40 $22.99 $21.90 $22.21 415 066
Jun 29, 2021 $22.96 $23.95 $22.26 $22.28 106 529
Jun 28, 2021 $24.77 $24.77 $23.22 $23.31 141 638
Jun 25, 2021 $24.33 $25.05 $23.22 $24.50 344 301
Jun 24, 2021 $24.05 $24.61 $21.55 $23.92 326 258
Jun 23, 2021 $25.20 $25.45 $23.27 $23.79 354 098
Jun 22, 2021 $26.25 $26.25 $24.70 $25.27 297 411
Jun 21, 2021 $24.49 $25.15 $24.25 $24.76 73 551
Click to get the best stock tips daily for free!

About Centessa Pharmaceuticals Limited

Centessa Pharmaceuticals Limited Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; and SerpinPC, an activated protein C inhibitor, which is in Phase IIa clinical development for the treatm... CNTA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT